Use of (RS) - S - S - cyclopropyl - (4 - [4 - [(1R, 2R) - 2 - hydroxy - 1-methylpropyl] oxy] - 5 - (trifluoromethyl) pyrimidine IL - 2 - phenyl] amino} sulfoximida) for the treatment of thyroid cancer, mesothelioma, squamous cell carcinomas of the esophagus or carcinoma colangiocelulares； Pharmaceutical composition； Combin Pharmaceutical Action.

• 收藏
• 分享

专利权人:

BAYER INTELLECTUAL PROPERTY GMBH

发明人:

DR. KORNACKER MARTIN

申请号：

CL2014002472

公开号：

CL2014002472A1

申请日:

2014.09.17

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

The invention relates to the use of (R)&mdash；S-cyclopropyl-S-(4-{[4-{[(1R,2R)-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulphoximide and/or (S)&mdash；S-cyclopropyl-S-(4-{[4-{[(1R,2R)-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulphoximide for the treatment of specific tumours.USO DE (RS)-S-CICLOPROPIL-S-(4-{[4-{[(1R,2R)-2-HIDROXI-1-METILPROPIL]OXI}-5-(TRIFLUOROMETIL)PIRIMIDIN-2-IL]AMINO}FENIL)SULFOXIMIDA PARA PREPARAR UN MEDICAMENTO ÚTIL PARA EL TRATAMIENTO DE CÁNCER DE TIROIDES, MESOTELIOMAS, CARCINOMA DE CÉLULAS ESCAMOSAS DEL ESÓFAGO O CARCINOMA COLANGIOCELULAR.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/